EQL Pharma AB (publ) financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
kr0.00M | kr0.00M | kr0.00M | kr0.00M | kr31.84M | kr49.76M | kr72.03M | kr179.84M | kr409.75M | kr259.91M | kr0.00M | kr0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 55.20% | 55.58% | 51.12% | 38.27% | 23.36% | 44.57% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | -0.75% | -1.13% | 6.29% | 12.46% | 9.48% | 15.90% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
kr0.14 | kr2.15 | kr0.00 | |||||||||
| Div. | Dividends |
|
kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00% | 0 |
| Sha. | Shares |
|
13.49m | 16.33m | 23.94m | 23.94m | 24.91m | 29.06m | 29.06m | 29.06m | 29.06m | 29.06m | 29.06m | 0m |
| OCF | Operating Cash Flow |
|
kr0.00M | kr0.00M | kr0.00M | kr0.00M | kr-1.54M | kr5.92M | kr6.69M | kr58.85M | kr41.83M | kr27.62M | kr0.00M | kr0.00M |
| FCF | Free Cash Flow |
|
kr0.00M | kr0.00M | kr0.00M | kr0.00M | kr-1.88M | kr5.52M | kr6.19M | kr55.75M | kr41.20M | kr27.16M | kr0.00M | kr0.00M |
| FCFS | Free Cash Flow Per Share |
|
kr0.00 | kr0.00 | kr0.00 | kr0.00 | kr-0.78 | kr-0.34 | kr-0.38 | kr0.13 | kr0.68 | kr0.24 | kr0.00 | kr0.00 |